Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
150
-
Total 13F shares, excl. options
-
55,107,197
-
Shares change
-
+5,999,457
-
Total reported value, excl. options
-
$319,615,726
-
Value change
-
+$33,772,157
-
Put/Call ratio
-
129%
-
Number of buys
-
87
-
Number of sells
-
-53
-
Price
-
$5.8
Significant Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q2 2021
198 filings reported holding CLVSQ - CLOVIS ONCOLOGY INC - COM as of Q2 2021.
CLOVIS ONCOLOGY INC - COM (CLVSQ) has 150 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,107,197 shares
.
Largest 10 shareholders include STATE STREET CORP (9,916,565 shares), VANGUARD GROUP INC (9,914,068 shares), BlackRock Inc. (8,815,674 shares), Palo Alto Investors LP (4,484,411 shares), MILLENNIUM MANAGEMENT LLC (2,304,374 shares), GEODE CAPITAL MANAGEMENT, LLC (1,846,733 shares), MORGAN STANLEY (1,583,663 shares), Ikarian Capital, LLC (1,129,473 shares), NORTHERN TRUST CORP (1,072,209 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (927,386 shares).
This table shows the top 150 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.